A Double-Blind Trial of Bradilan (Tetranicotinoylfructose) in Perniosis in General Practice

An initial double-blind cross-over study and a subsequent double-blind comparative study against placebo tablets has shown Bradilan (tetranicotinoylfructose) to be an effective treatment of chilblains. The difference between the active and placebo group was highly significant statistically with p < ·001